By Frank Prenesti
Date: Tuesday 11 Oct 2022
(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 44.47 |
| Change Today | $ 1.05 |
| % Change | 2.42 % |
| 52 Week High | $65.69 |
| 52 Week Low | $7.36 |
| Volume | 500,774 |
| Shares Issued | 180.09m |
| Market Cap | $8,009m |
| RiskGrade | 333 |
| Strong Buy | 4 |
| Buy | 3 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| Time | Volume / Share Price |
| 15:59 | 100 @ $44.43 |
| 15:59 | 100 @ $44.43 |
| 15:59 | 120 @ $44.43 |
| 15:59 | 100 @ $44.42 |
| 15:59 | 100 @ $44.43 |
You are here: research